Skip to content
Recall Observatory FDA recall evidence

Drug product

fentaNYL Citrate Injectable Solution, Narcotic, CII, 1250 mcg/25mL (50 mcg per mL), 25 mL, wells pharma of Houston, NDC 73702-204-25.

D-0505-2026

April 01, 2026

Class II

Product summary

Firm
Wells Pharma of Houston LLC
Event
Event 98694
Status
Ongoing
Classification
Class II
Quantity
50 syringes
Official record key
drug-enforcement:D-0505-2026

Official wording

Reason: cGMP deviations.

Code information: Lot 011226204250063, Exp Date 05/14/2026

Distribution pattern: U.S. Nationwide.

Derived failure modes

  • Manufacturing or process control

    reason.manufacturing_process_control · v1.0.0

    cGMP deviations